HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 118 | 124 | 95.2% | |
| HF004 | 2020 | 256 | 272 | 94.1% | |
| HF006 | 2021 | 237 | 298 | 79.5% | |
| HF006 | 2022 | 130 | 133 | 97.7% | |
| HF006 | 2023 | 434 | 457 | 95.0% |
